Balcom Alexandra's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 17,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 99,233 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.96 per share. | 05 Jan 2026 | 1,929 | 85,231 | - | 98.0 | 188,965 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.33 per share. | 05 Jan 2026 | 1,635 | 81,958 | - | 97.3 | 159,135 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.75 per share. | 05 Jan 2026 | 1,321 | 83,593 | - | 96.8 | 127,807 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.85 per share. | 05 Jan 2026 | 1,119 | 87,160 | - | 96.8 | 108,375 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 05 Jan 2026 | 871 | 88,279 | - | 96.1 | 83,668 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.52 per share. | 05 Jan 2026 | 317 | 84,914 | - | 98.5 | 31,231 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.40 per share. | 05 Jan 2026 | 225 | 81,733 | - | 98.4 | 22,140 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 34,500 | 161,656 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 22 Dec 2025 | 34,500 | 89,150 | - | 1.1 | 37,260 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 110.31 per share. | 08 Dec 2025 | 6,984 | 54,750 | - | 110.3 | 770,405 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 111.32 per share. | 08 Dec 2025 | 100 | 54,650 | - | 111.3 | 11,132 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 13,125 | 34,375 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 17 Nov 2025 | 13,125 | 81,734 | - | 72.4 | 949,594 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 17 Nov 2025 | 6,875 | 68,609 | - | 6.9 | 47,369 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 6,875 | 29,101 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.27 per share. | 17 Nov 2025 | 5,055 | 62,114 | - | 103.3 | 522,030 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.58 per share. | 17 Nov 2025 | 4,496 | 70,363 | - | 100.6 | 452,208 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 93.80 per share. | 17 Nov 2025 | 3,609 | 78,125 | - | 93.8 | 338,524 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.12 per share. | 17 Nov 2025 | 3,266 | 74,859 | - | 95.1 | 310,662 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.13 per share. | 17 Nov 2025 | 3,194 | 67,169 | - | 102.1 | 326,203 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 729 | 33,646 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 17 Nov 2025 | 729 | 62,463 | - | 72.3 | 52,743 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 104.54 per share. | 17 Nov 2025 | 509 | 61,734 | - | 104.5 | 53,211 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.68 per share. | 17 Nov 2025 | 380 | 61,734 | - | 103.7 | 39,398 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.61 per share. | 17 Nov 2025 | 220 | 62,243 | - | 103.6 | 22,794 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.57 per share. | 15 Oct 2025 | 1,683 | 61,734 | - | 85.6 | 144,014 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 1,683 | 28,979 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 15 Oct 2025 | 1,683 | 63,417 | - | 18.9 | 31,859 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 20,000 | 30,662 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 20,000 | 81,734 | - | 18.9 | 378,600 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 13,125 | 50,662 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 13,125 | 81,734 | - | 18.9 | 248,456 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.75 per share. | 13 Oct 2025 | 12,280 | 69,454 | - | 85.8 | 1,053,010 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.73 per share. | 13 Oct 2025 | 12,266 | 63,330 | - | 88.7 | 1,088,362 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 13 Oct 2025 | 6,875 | 68,609 | - | 6.9 | 47,369 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 6,875 | 35,976 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.90 per share. | 13 Oct 2025 | 6,138 | 75,596 | - | 87.9 | 539,530 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.63 per share. | 13 Oct 2025 | 5,820 | 63,634 | - | 86.6 | 504,187 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.67 per share. | 13 Oct 2025 | 1,700 | 61,934 | - | 87.7 | 149,039 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.22 per share. | 13 Oct 2025 | 1,596 | 61,734 | - | 89.2 | 142,395 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.90 per share. | 13 Oct 2025 | 200 | 61,734 | - | 88.9 | 17,780 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.43 per share. | 01 Oct 2025 | 19,030 | 62,704 | - | 85.4 | 1,625,733 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 01 Oct 2025 | 16,787 | 78,521 | - | 6.9 | 115,662 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 16,787 | 42,851 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 3,213 | 63,787 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 01 Oct 2025 | 3,213 | 81,734 | - | 18.9 | 60,822 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.37 per share. | 01 Oct 2025 | 970 | 61,734 | - | 86.4 | 83,779 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 20,000 | 59,638 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.06 per share. | 29 Sep 2025 | 20,000 | 61,734 | - | 85.1 | 1,701,200 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 29 Sep 2025 | 20,000 | 81,734 | - | 6.9 | 137,800 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 7,588 | 79,638 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.01 per share. | 29 Sep 2025 | 7,588 | 61,734 | - | 85.0 | 645,056 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 29 Sep 2025 | 7,588 | 69,322 | - | 6.9 | 52,281 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 14,700 | 67,000 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.10 per share. | 15 Jul 2025 | 14,700 | 61,734 | - | 85.1 | 1,250,970 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 15 Jul 2025 | 14,700 | 76,434 | - | 18.9 | 278,271 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 15 Jul 2025 | 5,300 | 67,034 | - | 18.9 | 100,329 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 5,300 | 81,700 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 82.67 per share. | 15 Jul 2025 | 2,484 | 64,550 | - | 82.7 | 205,352 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 83.87 per share. | 15 Jul 2025 | 1,888 | 62,662 | - | 83.9 | 158,347 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.91 per share. | 15 Jul 2025 | 874 | 61,788 | - | 84.9 | 74,211 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.48 per share. | 15 Jul 2025 | 54 | 61,734 | - | 85.5 | 4,616 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.02 per share. | 27 Jun 2025 | 20,000 | 61,734 | - | 80.0 | 1,600,400 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 27 Jun 2025 | 20,000 | 81,734 | - | 18.9 | 378,600 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2025 | 20,000 | 87,000 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 18,750 | 65,750 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.54 per share. | 06 Jan 2025 | 2,173 | 61,734 | - | 80.5 | 175,013 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.28 per share. | 06 Jan 2025 | 1,152 | 64,598 | - | 78.3 | 90,179 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 06 Jan 2025 | 691 | 63,907 | - | 79.3 | 54,817 | Class A Common Stock |
| Nuvalent Inc (Class A) | Balcom Alexandra | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 17 Dec 2024 | 8,972 | 47,000 | - | 6.9 | 61,817 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2024 | 8,972 | 87,226 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 17 Dec 2024 | 4,728 | 38,028 | - | 1.1 | 5,106 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2024 | 4,728 | 196,156 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Balcom Alexandra | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 29 Nov 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 10,000 | 84,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.69 per share. | 29 Nov 2024 | 8,142 | 35,158 | - | 95.7 | 779,108 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.25 per share. | 29 Nov 2024 | 1,858 | 33,300 | - | 96.3 | 178,833 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 31 Oct 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2024 | 10,000 | 94,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 31 Oct 2024 | 6,320 | 35,000 | - | 89.2 | 563,554 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.25 per share. | 31 Oct 2024 | 1,980 | 41,320 | - | 88.3 | 174,735 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.31 per share. | 31 Oct 2024 | 1,600 | 33,400 | - | 90.3 | 144,496 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.94 per share. | 31 Oct 2024 | 100 | 33,300 | - | 90.9 | 9,094 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 10,000 | 104,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 30 Sep 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 30 Sep 2024 | 5,032 | 36,263 | - | 101.1 | 508,886 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.89 per share. | 30 Sep 2024 | 2,963 | 33,300 | - | 101.9 | 301,900 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.09 per share. | 30 Sep 2024 | 1,305 | 41,295 | - | 100.1 | 130,617 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.88 per share. | 30 Sep 2024 | 700 | 42,600 | - | 98.9 | 69,216 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 10,000 | 114,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 30 Aug 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 83.87 per share. | 30 Aug 2024 | 5,231 | 38,069 | - | 83.9 | 438,724 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.55 per share. | 30 Aug 2024 | 4,481 | 33,588 | - | 84.6 | 378,869 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.96 per share. | 30 Aug 2024 | 288 | 33,300 | - | 86.0 | 24,756 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 10,000 | 124,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 31 Jul 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.44 per share. | 31 Jul 2024 | 5,723 | 36,084 | - | 79.4 | 454,635 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.38 per share. | 31 Jul 2024 | 1,649 | 34,435 | - | 80.4 | 132,547 | Class A Common Stock |